EUVIMEDEUVIMED entdecken
Crossref

Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis

Lijun Zhi, Lin Yuan

Mammalian Genome · 2026

DOI: 10.1007/s00335-025-10182-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mammalian Genome, 2026. Verfasst von Lijun Zhi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210004,…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, HSP90 Heat-Shock Proteins, beta Catenin, Lactones. Die Arbeit nennt 37 Literaturangaben. Gefördert von: basic research fund project of the Second People's Hospital of Huai'an City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsHSP90 Heat-Shock Proteinsbeta CateninLactonesHumansAnimalsCell Line, TumorMiceCell ProliferationDisease ProgressionApoptosisXenograft Model Antitumor AssaysSignal TransductionCell MovementGene Expression Regulation, NeoplasticMice, NudeSesquiterpenes, Eudesmane

Stichwörter der Autor:innen

AlantolactoneBladder cancerHSP90AB1LRP5/β-cateninUbiquitination

Substanzen

HSP90 Heat-Shock Proteinsbeta CateninHSP90AB1 protein, humanLactonesalantolactoneSesquiterpenes, Eudesmane

Autor:innen und Institutionen

  • Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210004, Jiangsu Province, China.
  • Department of Anesthesiology, The Second People's Hospital of Huai'an (The Affiliated Huai'an Hospital of Xuzhou Medical University), No. 155, Hanzhong Road, Qinhuai District, Huai'an, 223001, Jiangsu Province, China.
  • Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210004, Jiangsu Province, China. yuanlin47@126.com.

Förderung

  • basic research fund project of the Second People's Hospital of Huai'an City

Zitieren

APA

Zhi, L., & Yuan, L. (2026). Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis. Mammalian Genome. https://doi.org/10.1007/s00335-025-10182-4

Vancouver

Zhi L, Yuan L. Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis. Mammalian Genome. 2026. doi:10.1007/s00335-025-10182-4

BibTeX
@article{Zhi2026,
  author = {Zhi, Lijun and Yuan, Lin},
  title = {Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis},
  journal = {Mammalian Genome},
  year = {2026},
  doi = {10.1007/s00335-025-10182-4}
}
Kostenlos starten →